Oramed Pharmaceuticals Inc. (ORMP)Healthcare | Biotechnology | New York, United States | NasdaqCM
3.88 USD
+0.02
(0.518%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 3.88 Short-term: ★★☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ★★★★☆ |
Hot Take | April 11, 2026, 3:02 p.m. EDT
ORMP is a high-yield stock with a dividend yield of 7.08%, which is attractive for income-focused investors. However, the short-term price forecast indicates a slight decline, and the long-term fundamentals are weak with a negative forward PE and low revenue per share. The stock is trading near its 52-week low, suggesting potential for a rebound, but the overall outlook is cautious due to the lack of analyst coverage and weak financial metrics. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.035146 |
| AutoETS | 0.037379 |
| AutoTheta | 0.037745 |
| MSTL | 0.039052 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 82% |
| H-stat | 0.35 |
| Ljung-Box p | 0.004 |
| Jarque-Bera p | 0.988 |
| Excess Kurtosis | -0.10 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Ex Dividend Date | 2026-01-15 |
| Last Dividend Date | 2026-01-15 |
| Debt to Equity Ratio | 0.413 |
| Revenue per Share | 0.048 |
| Market Cap | 156,931,184 |
| Trailing P/E | 2.57 |
| Forward P/E | -48.50 |
| Beta | 1.25 |
| Profit Margins | 3202.50% |
| Website | https://www.oramed.com |
As of April 11, 2026, 3:02 p.m. EDT: Options speculators are showing mixed signals. The calls and puts for near-term expirations have limited volume and open interest, with the ATM strikes showing higher interest. The IV for calls is relatively low, suggesting limited bullish sentiment, while puts have slightly higher IV, indicating some bearish positioning. However, the overall activity is minimal, suggesting a lack of strong directional bias from options traders.
| Date | Dividend | Yield % |
|---|---|---|
| 2026-01-16 | 0.25 | 6.793478 |
| Attribute | Value |
|---|---|
| 52 Week Change | 0.71555555 |
| Address1 | 1,185 Avenue of the Americas |
| Address2 | Third Floor |
| All Time High | 31.73 |
| All Time Low | 1.67 |
| Ask | 4.88 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 95,820 |
| Average Daily Volume3 Month | 152,319 |
| Average Volume | 152,319 |
| Average Volume10Days | 95,820 |
| Beta | 1.253 |
| Bid | 2.81 |
| Bid Size | 2 |
| Book Value | 5.086 |
| City | New York |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 3.88 |
| Current Ratio | 6.983 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 3.96 |
| Day Low | 3.82 |
| Debt To Equity | 0.413 |
| Display Name | Oramed Pharmaceuticals |
| Dividend Date | 1,769,385,600 |
| Dividend Rate | 0.25 |
| Dividend Yield | 6.46 |
| Earnings Timestamp End | 1,778,875,200 |
| Earnings Timestamp Start | 1,778,875,200 |
| Ebitda | -14,967,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -2.129 |
| Enterprise To Revenue | 15.931 |
| Enterprise Value | 31,862,174 |
| Eps Forward | -0.08 |
| Eps Trailing Twelve Months | 1.51 |
| Esg Populated | 0 |
| Ex Dividend Date | 1,768,521,600 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 3.4352 |
| Fifty Day Average Change | 0.44480014 |
| Fifty Day Average Change Percent | 0.12948304 |
| Fifty Two Week Change Percent | 71.55556 |
| Fifty Two Week High | 3.96 |
| Fifty Two Week High Change | -0.07999992 |
| Fifty Two Week High Change Percent | -0.020202002 |
| Fifty Two Week Low | 1.98 |
| Fifty Two Week Low Change | 1.9000001 |
| Fifty Two Week Low Change Percent | 0.959596 |
| Fifty Two Week Range | 1.98 - 3.96 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,178,026,200,000 |
| Float Shares | 29,812,474 |
| Forward Eps | -0.08 |
| Forward P E | -48.500004 |
| Free Cashflow | 3,920,000 |
| Full Exchange Name | NasdaqCM |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0064999997 |
| Gross Profits | 13,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.18047 |
| Held Percent Institutions | 0.27406 |
| Implied Shares Outstanding | 40,446,179 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Dividend Date | 1,768,521,600 |
| Last Dividend Value | 0.25 |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,358,899,200 |
| Last Split Factor | 1:12 |
| Long Business Summary | Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York. |
| Long Name | Oramed Pharmaceuticals Inc. |
| Market | us_market |
| Market Cap | 156,931,184 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_12191105 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | 63,242,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 156,526,712 |
| Number Of Analyst Opinions | 1 |
| Open | 3.82 |
| Operating Cashflow | -9,145,000 |
| Operating Margins | -7.544 |
| Payout Ratio | 0.0 |
| Phone | 844 967 2633 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 3.88 |
| Post Market Time | 1,776,456,605 |
| Previous Close | 3.86 |
| Price Hint | 4 |
| Price To Book | 0.76287854 |
| Price To Sales Trailing12 Months | 78.46559 |
| Profit Margins | 32.025 |
| Quick Ratio | 6.62 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0200002 |
| Regular Market Change Percent | 0.51814 |
| Regular Market Day High | 3.96 |
| Regular Market Day Low | 3.82 |
| Regular Market Day Range | 3.82 - 3.96 |
| Regular Market Open | 3.82 |
| Regular Market Previous Close | 3.86 |
| Regular Market Price | 3.88 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 87,468 |
| Return On Assets | -0.048839998 |
| Return On Equity | 0.37101 |
| Revenue Per Share | 0.048 |
| Sand P52 Week Change | 0.36506534 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 40,446,179 |
| Shares Percent Shares Out | 0.0139 |
| Shares Short | 562,979 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 556,109 |
| Short Name | Oramed Pharmaceuticals Inc. |
| Short Percent Of Float | 0.0165 |
| Short Ratio | 4.47 |
| Source Interval | 15 |
| State | NY |
| Symbol | ORMP |
| Target High Price | 6.25 |
| Target Low Price | 6.25 |
| Target Mean Price | 6.25 |
| Target Median Price | 6.25 |
| Total Cash | 125,894,000 |
| Total Cash Per Share | 3.113 |
| Total Debt | 825,000 |
| Total Revenue | 2,000,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 1.51 |
| Trailing P E | 2.5695364 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 2.76515 |
| Two Hundred Day Average Change | 1.11485 |
| Two Hundred Day Average Change Percent | 0.40317887 |
| Type Disp | Equity |
| Volume | 87,468 |
| Website | https://www.oramed.com |
| Zip | 10,036 |